Key Points
- Director Patrick Gottschalk bought 20,000 shares of American Vanguard at $2.92 each, a $58,400 transaction that increased his direct stake by 15.78% to 146,705 shares.
- American Vanguard stock was down 1.6% to $2.67, and the company remains small in market value at about $76.3 million, with shares trading well below the 200-day moving average of $3.95.
- The company recently reported a loss of $0.14 per share, missing analyst estimates, though revenue came in slightly above expectations at $123.57 million. Analyst sentiment is mixed, with an average Hold rating and a $12.00 price target.
American Vanguard Corporation (NYSE:AVD - Get Free Report) Director Patrick Gottschalk acquired 20,000 shares of the stock in a transaction that occurred on Tuesday, May 12th. The stock was acquired at an average price of $2.92 per share, for a total transaction of $58,400.00. Following the transaction, the director directly owned 146,705 shares of the company's stock, valued at $428,378.60. This represents a 15.78% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
American Vanguard Trading Down 1.6%
Shares of AVD stock opened at $2.67 on Wednesday. The company has a debt-to-equity ratio of 1.39, a quick ratio of 1.41 and a current ratio of 2.32. American Vanguard Corporation has a 52-week low of $2.05 and a 52-week high of $5.92. The company has a market capitalization of $76.30 million, a PE ratio of -1.68 and a beta of 1.48. The business's fifty day moving average is $2.85 and its 200 day moving average is $3.95.
American Vanguard (NYSE:AVD - Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The basic materials company reported ($0.14) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.08). American Vanguard had a negative return on equity of 4.13% and a negative net margin of 8.71%.The business had revenue of $123.57 million during the quarter, compared to analysts' expectations of $120.00 million.
Institutional Investors Weigh In On American Vanguard
A number of large investors have recently added to or reduced their stakes in the company. Empowered Funds LLC raised its position in American Vanguard by 97.0% during the first quarter. Empowered Funds LLC now owns 84,078 shares of the basic materials company's stock valued at $209,000 after purchasing an additional 41,388 shares in the last quarter. Renaissance Technologies LLC raised its position in American Vanguard by 33.5% during the first quarter. Renaissance Technologies LLC now owns 218,300 shares of the basic materials company's stock valued at $544,000 after purchasing an additional 54,800 shares in the last quarter. Gamco Investors INC. ET AL raised its position in American Vanguard by 13.3% during the first quarter. Gamco Investors INC. ET AL now owns 68,000 shares of the basic materials company's stock valued at $169,000 after purchasing an additional 8,000 shares in the last quarter. R Squared Ltd purchased a new stake in American Vanguard during the first quarter valued at about $28,000. Finally, Canal Capital Management LLC purchased a new stake in American Vanguard during the first quarter valued at about $75,000. Hedge funds and other institutional investors own 79.00% of the company's stock.
Analysts Set New Price Targets
Separately, Weiss Ratings downgraded American Vanguard from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Monday. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average price target of $12.00.
View Our Latest Analysis on American Vanguard
About American Vanguard
(
Get Free Report)
American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.
The company's product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
